Regulatory Issues for Life Sciences Companies in 2025

ArentFox Schiff – Webinar@AFS

  • Date & Time
    -
  • Location

    Online

  • Event Type
    Webinar
  • Additional Information
    Add to Calendar Disabled

ArentFox Schiff professionals will discuss recent matters that directly impact the life sciences industry and its trajectory.

Administrative shifts are leading to alterations in the operations of the life sciences sector. Recent executive orders have influenced aspects such as the FDA’s regulatory focus and the conduct of clinical trials.

Philip English, a former US Congressman and current Co-Chair of the Government Relations practice at ArentFox Schiff, will address recent and prospective changes introduced by the new administration and their impact on the life sciences industry.

ArentFox Schiff attorneys will also discuss the issues impacting the life sciences industry including: 

  • FDA inspections and Good Manufacturing Practices
  • Drug Supply Chain Security Act compliance
  • Country of origin issues
  • BIOSECURE Act

Contacts

Continue Reading